Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255

1.

Comparison of magnetic resonance elastography and gadoxetate disodium-enhanced magnetic resonance imaging for the evaluation of hepatic fibrosis.

Choi YR, Lee JM, Yoon JH, Han JK, Choi BI.

Invest Radiol. 2013 Aug;48(8):607-13. doi: 10.1097/RLI.0b013e318289ff8f.

PMID:
23538889
2.

Noninvasive assessment of hepatic fibrosis using gadoxetate-disodium-enhanced 3T MRI.

Jang YJ, Cho SH, Bae JH, Kim GC, Ryeom H, Kim HJ, Shin KM, Lee HJ.

Ann Hepatol. 2013 Nov-Dec;12(6):926-34.

3.

Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.

Watanabe H, Kanematsu M, Goshima S, Kondo H, Onozuka M, Moriyama N, Bae KT.

Radiology. 2011 Apr;259(1):142-50. doi: 10.1148/radiol.10100621. Epub 2011 Jan 19.

PMID:
21248234
4.

Three-Tesla magnetic resonance elastography for hepatic fibrosis: comparison with diffusion-weighted imaging and gadoxetic acid-enhanced magnetic resonance imaging.

Park HS, Kim YJ, Yu MH, Choe WH, Jung SI, Jeon HJ.

World J Gastroenterol. 2014 Dec 14;20(46):17558-67. doi: 10.3748/wjg.v20.i46.17558.

5.

Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio.

Goshima S, Kanematsu M, Watanabe H, Kondo H, Kawada H, Moriyama N, Bae KT.

J Magn Reson Imaging. 2012 Nov;36(5):1148-53. doi: 10.1002/jmri.23758. Epub 2012 Jul 30.

PMID:
22848019
6.

Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis.

Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Tatsumi A, Enomoto N, Matsuda M, Fujii H, Onishi H.

Magn Reson Imaging. 2015 Jan;33(1):26-30. doi: 10.1016/j.mri.2014.10.003. Epub 2014 Oct 13.

PMID:
25308096
7.

Hepatic fibrosis: prospective comparison of MR elastography and US shear-wave elastography for evaluation.

Yoon JH, Lee JM, Joo I, Lee ES, Sohn JY, Jang SK, Lee KB, Han JK, Choi BI.

Radiology. 2014 Dec;273(3):772-82. doi: 10.1148/radiol.14132000. Epub 2014 Jul 7.

PMID:
25007047
8.

MRI-based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography.

Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Enomoto N, Matsuda M, Fujii H, Onishi H.

J Magn Reson Imaging. 2015 Jul;42(1):204-10. doi: 10.1002/jmri.24760. Epub 2014 Sep 15.

PMID:
25223820
9.

Magnetic resonance elastography of liver: influence of intravenous gadolinium administration on measured liver stiffness.

Hallinan JT, Alsaif HS, Wee A, Venkatesh SK.

Abdom Imaging. 2015 Apr;40(4):783-8. doi: 10.1007/s00261-014-0275-x.

PMID:
25331568
10.

Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging.

Feier D, Balassy C, Bastati N, Stift J, Badea R, Ba-Ssalamah A.

Radiology. 2013 Nov;269(2):460-8. doi: 10.1148/radiol.13122482. Epub 2013 Jul 22.

PMID:
23878281
11.

MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia.

Kim BH, Lee JM, Lee YJ, Lee KB, Suh KS, Han JK, Choi BI.

J Magn Reson Imaging. 2011 Nov;34(5):1110-6. doi: 10.1002/jmri.22723. Epub 2011 Sep 19.

PMID:
21932355
12.

Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging.

Wang Y, Ganger DR, Levitsky J, Sternick LA, McCarthy RJ, Chen ZE, Fasanati CW, Bolster B, Shah S, Zuehlsdorff S, Omary RA, Ehman RL, Miller FH.

AJR Am J Roentgenol. 2011 Mar;196(3):553-61. doi: 10.2214/AJR.10.4580.

13.

Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.

Kim JY, Lee SS, Byun JH, Kim SY, Park SH, Shin YM, Lee MG.

AJR Am J Roentgenol. 2013 Aug;201(2):322-31. doi: 10.2214/AJR.12.9478.

PMID:
23883212
14.

Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography.

Asbach P, Klatt D, Schlosser B, Biermer M, Muche M, Rieger A, Loddenkemper C, Somasundaram R, Berg T, Hamm B, Braun J, Sack I.

Radiology. 2010 Oct;257(1):80-6. doi: 10.1148/radiol.10092489. Epub 2010 Aug 2.

PMID:
20679447
15.

Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.

Yamada A, Hara T, Li F, Fujinaga Y, Ueda K, Kadoya M, Doi K.

Radiology. 2011 Sep;260(3):727-33. doi: 10.1148/radiol.11100586. Epub 2011 Jun 28.

PMID:
21712472
16.

Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C.

Ichikawa S, Motosugi U, Ichikawa T, Sano K, Morisaka H, Enomoto N, Matsuda M, Fujii H, Araki T.

Magn Reson Med Sci. 2012;11(4):291-7.

17.

The value of gadoxetate disodium-enhanced MR imaging for predicting posthepatectomy liver failure after major hepatic resection: a preliminary study.

Cho SH, Kang UR, Kim JD, Han YS, Choi DL.

Eur J Radiol. 2011 Nov;80(2):e195-200. doi: 10.1016/j.ejrad.2011.08.008. Epub 2011 Sep 9.

PMID:
21908121
18.

Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.

Gupta RT, Iseman CM, Leyendecker JR, Shyknevsky I, Merkle EM, Taouli B.

AJR Am J Roentgenol. 2012 Jul;199(1):35-43. doi: 10.2214/AJR.11.7757.

PMID:
22733891
19.

Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI.

Bashir MR, Breault SR, Braun R, Do RK, Nelson RC, Reeder SB.

Acad Radiol. 2014 Jun;21(6):726-32. doi: 10.1016/j.acra.2014.02.005. Epub 2014 Apr 6.

PMID:
24717550
20.

Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index.

Huwart L, Sempoux C, Salameh N, Jamart J, Annet L, Sinkus R, Peeters F, ter Beek LC, Horsmans Y, Van Beers BE.

Radiology. 2007 Nov;245(2):458-66.

PMID:
17940304

Supplemental Content

Support Center